BioLineRx to Report Second Quarter 2025 Results on August 14, 2025
Provided By PR Newswire
Last update: Aug 7, 2025
Management to Hold Conference Call at 8:30 a.m. EDT
TEL AVIV, Israel, Aug. 7, 2025 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that it will release its unaudited financial results for the second quarter ended June 30, 2025 on Thursday, August 14, 2025, before the U.S. markets open.
Read more at prnewswire.com
